After a poor summer 2025, a slightly better September, we cut our 2025F-2026F-2027F visitor estimates by 2%, our EBITDAL by 4%, our EPS by 6-7%, and our target price from €43 to €41. We are 8% below consensus EBITDAL 2025F, 5% below for 2026F and 15% below consensus EPS 2025F, 10% below 2026F. We are more prudent on the box office recovery, with attendance 2025F-2026F-2027F at 63.4%, 66.5% and 66.3% of pre-Covid levels, down from a post-Covid “peak” of 69.5% in 2023 (‘Barbie') and compared to 63...
Kendrion's transformation into a dedicated industrial company with a sound balance sheet is complete. In three major strategic steps Kendrion has removed its exposure to the struggling global automotive industry. This exposure has been a drag on the results and cash flow generating power of the company since 2018. We also believe investors applied a valuation discount to Kendrion to reflect this. The sale of the bulk of the automotive business (US and EU) to Solero Technologies in April 2024, th...
Over the past month, the EPRA BELUX index has underperformed (total return) the EPRA Developed Europe index by 3.2%, the STOXX50 by 5.4%, and the BEL20 by 3.6%. This underperformance relative to the EPRA Developed Europe Index can be attributed to the stronger performance of UK real estate compared to eurodenominated stocks, as UK equities led the recovery following a selloff in August. Additionally, the BELUX region had already posted strong year-to-date performance, which limited further upsid...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.